Frische Früchte und Gemüse sowie daraus gewonnene Produkte werden oft als 'lebendig' bezeichnet, da sie aktive Verbindungen enthalten. Die Enzyme, um die es geht, sind in größeren Mengen in rohen Produkten vorhanden und fungieren als Aktivatoren für verschiedene Reaktionen im Organismus. Sie sind sehr temperaturempfindlich, da sie während des Kochens und der Pasteurisierung inaktiviert werden. Wissenschaftliche Studien haben gezeigt, dass einige Nahrungsmittel-Enzyme aus der Nahrung als Ganzes aufgenommen werden und ihre Aktivität im menschlichen Körper zeigen. Bromelain, um das es geht, ist eines der bekannteren Enzyme, die aus essbaren Ananasfrüchten gewonnen werden.
Bromelain: A Proteolytic Enzyme Complex Extracted from Edible Pineapple (*Ananas comosus*)
The term "bromelain"—occasionally referred to as "bromelin" in some literary sources—encompasses a collective designation for five distinct proteolytic enzymes systematically extracted from both the fruit clusters and stalks of the edible pineapple (*Ananas comosus*), a tropical plant belonging to the Bromeliaceae family. As a member of the protease class (biological catalysts that facilitate the hydrolysis of peptide bonds within proteins), bromelain has garnered widespread recognition across diverse fields, including clinical medicine, athletic supplementation, and culinary applications. Its most commercially prevalent formulation is a fine, yellowish powder that retains the signature sweet-tart aromatic profile of its source material—ripe pineapple. However, it is critical to emphasize that not all bromelain-containing preparations available on the market exhibit equivalent biological efficacy. The enzymatic activity varies significantly depending on the extraction source: empirical research consistently demonstrates that extracts derived from the whole fruit possess substantially higher potency compared to those obtained solely from the stalks. Notably, when administered orally, bromelain undergoes intestinal absorption at an approximate rate of 40%, with the enzyme being assimilated in its fully active, unaltered conformation, thereby preserving its catalytic functionality. The half-life of bromelain within the human body—defined as the duration during which it maintains therapeutic activity—is estimated by researchers to range between six and nine hours, positioning it as a relatively durable supplement in terms of sustained enzymatic action.
Bromelain: scientifically validated multifaceted health benefits and mechanisms of action
A substantial body of clinical research has meticulously documented the multifaceted therapeutic potential of bromelain, a complex of proteolytic enzymes derived from pineapple stems. Key findings indicate that this biochemical compound:
• **Facilitates digestive function and alleviates gastrointestinal discomfort** – it demonstrates marked efficacy in mitigating functional dyspepsia symptoms in individuals without *Helicobacter pylori* infection, particularly when administered in conjunction with other bioactive nutraceuticals;
• **Modulates immune system responses** – by selectively inhibiting surface receptors on immune cells that are primarily responsive to pro-inflammatory mediators (such as interleukin-1 and tumor necrosis factor-α), suggesting potential applications in managing autoimmune-driven inflammatory conditions;
• **Accelerates skeletal muscle recovery** – proteolytic enzymes (including bromelain and papain) detected in serum have been shown to attenuate exercise-induced muscle damage, likely by reducing the accumulation of acidic metabolic byproducts;
• **Exhibits anticoagulant properties** – it suppresses platelet aggregation and endothelial adhesion, which may lower thrombotic risk and enhance microcirculatory flow;
• **Provides cardioprotective benefits** – both *in vitro* and *in vivo* studies have confirmed bromelain’s ability to reduce oxidative stress biomarkers in cardiac tissue, thereby supporting cardiovascular health;
• **Delivers analgesic and anti-inflammatory effects** – its pain-relieving properties are comparable to those of nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin, yet without the associated gastrointestinal adverse effects;
• **Regulates lipid metabolism** – it downregulates lipoprotein lipase-binding protein (LPL) and fatty acid synthase (FAS) expression, which may inhibit triglyceride synthesis and reduce lipid storage in adipocytes;
• **Inhibits adipogenesis** – by interfering with signaling pathways involved in preadipocyte differentiation, bromelain may counteract pathological fat tissue expansion, making it relevant for obesity and metabolic syndrome prevention.
Bromelain: Adverse reactions and precautions for supplementation
While bromelain is generally regarded as a well-tolerated supplement with a broad range of therapeutic applications, there are specific clinical scenarios in which its administration necessitates heightened vigilance and individualized consultation with a qualified healthcare provider. Due to its capacity to inhibit platelet aggregation, this enzymatic compound may be associated with an elevated risk of hemorrhagic events, representing a critical consideration for patients undergoing anticoagulant therapy or those who have recently undergone surgical interventions. Furthermore, existing evidence indicates that elevated dosages exceeding 800 milligrams per kilogram of body weight per day may provoke gastrointestinal disturbances, including but not limited to abdominal distension, emetic episodes, diarrhea, or constipation. Additionally, peer-reviewed literature documents isolated instances of hypersensitivity reactions, characterized by dermatological manifestations (e.g., urticaria, erythema), irritation of the mucosal membranes within the upper respiratory tract, or soft tissue edema.
